AxoGen (AXGN) Misses Q2 EPS by 24c
Tweet
Share
E-mailGet Alerts AXGN Hot Sheet
Join SI Premium – FREE
AxoGen (NASDAQ: AXGN) reported Q2 EPS of ($0.12), $0.24 worse than the analyst estimate of $0.12. Revenue for the quarter came in at $69.7 million versus the consensus estimate of $67.1 million.
For earnings history and earnings-related data on AxoGen (AXGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Societe Generale SA (GLE:FP) (SCGLY) to Neutral
- Goldman Sachs Upgrades Deutsche Bank (DBK:GR) (DB) to Buy
- UBS Upgrades Zhejiang Leapmotor Technology (9863:HK) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
